>
PURE Biosciences Inc logo

PURE - PURE Biosciences Inc Share Price

$0.65 0.0  0.0%

Last Trade - 20/04/21

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £40.7m
Enterprise Value £38.6m
Revenue £6.23m
Position in Universe 5543rd / 6852
Bullish
Bearish
Unlock PURE Revenue
Momentum
Relative Strength (%)
1m -18.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -68.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jul 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.73 1.29 1.83 1.77 1.91 6.92 +56.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 January 2021, PUREBiosciences Inc revenues increased from $747K to $2.5M. Netloss decreased 57% to $775K. Revenues reflect Net productsales increase from $747K to $2.3M. Lower net loss reflectsInterest expense, net decrease of 33% to $2K (expense).Basic Earnings per Share excluding Extraordinary Itemsincreased from -$0.02 to -$0.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PURE Revenue Unlock PURE Revenue

Net Income

PURE Net Income Unlock PURE Revenue

Normalised EPS

PURE Normalised EPS Unlock PURE Revenue

PE Ratio Range

PURE PE Ratio Range Unlock PURE Revenue

Dividend Yield Range

PURE Dividend Yield Range Unlock PURE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PURE EPS Forecasts Unlock PURE Revenue
Profile Summary

PURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company's technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC). It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains and food processors. It is testing and continuing development of PURE Control to utilize PURE Control as a direct food contact processing aid for raw meats, including beef and pork. In addition to PURE Hard Surface and PURE Control, it manufactures and sells SDC-based products for end use; products preserved with SDC, and SDC as a raw material ingredient for manufacturing use. These products include PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION.

Directors
Last Annual July 31st, 2020
Last Interim January 31st, 2021
Incorporated February 28, 2011
Public Since May 3, 2004
No. of Shareholders: n/a
No. of Employees: 10
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 87,223,141
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
PURE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PURE
Upcoming Events for PURE
Frequently Asked Questions for PURE Biosciences Inc
What is the PURE Biosciences Inc share price?

As of 20/04/21, shares in PURE Biosciences Inc are trading at $0.65, giving the company a market capitalisation of £40.7m. This share price information is delayed by 15 minutes.

How has the PURE Biosciences Inc share price performed this year?

Shares in PURE Biosciences Inc are currently trading at $0.65 and the price has moved by 4.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PURE Biosciences Inc price has moved by -30.56% over the past year.

What are the analyst and broker recommendations for PURE Biosciences Inc?

Of the analysts with advisory recommendations for PURE Biosciences Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for PURE Biosciences Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will PURE Biosciences Inc next release its financial results?

PURE Biosciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-31
What is the PURE Biosciences Inc dividend yield?

PURE Biosciences Inc does not currently pay a dividend.

Does PURE Biosciences Inc pay a dividend?

PURE Biosciences Inc does not currently pay a dividend.

When does PURE Biosciences Inc next pay dividends?

PURE Biosciences Inc does not currently pay a dividend.

How do I buy PURE Biosciences Inc shares?

To buy shares in PURE Biosciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of PURE Biosciences Inc?

Shares in PURE Biosciences Inc are currently trading at $0.65, giving the company a market capitalisation of £40.7m.

Where are PURE Biosciences Inc shares listed? Where are PURE Biosciences Inc shares listed?

Here are the trading details for PURE Biosciences Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: PURE
What kind of share is PURE Biosciences Inc?

Based on an overall assessment of its quality, value and momentum, PURE Biosciences Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a PURE Biosciences Inc share price forecast 2021?

We were not able to load any forecast data for PURE Biosciences Inc.

How can I tell whether the PURE Biosciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PURE Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been -63.11%. At the current price of $0.65, shares in PURE Biosciences Inc are trading at -41.91% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the PURE Biosciences Inc PE Ratio?

The PURE Biosciences Inc PE ratio based on its reported earnings over the past 12 months is 62.98. The shares are currently trading at $0.65.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of PURE Biosciences Inc?

PURE Biosciences Inc's management team is headed by:

Tom Lee - CHM
Mark Elliott - CFO
Ivan Chen - IND
Tom Myers - COO
Dale Okuno - IND
Jason Kawata - VPR
Kristin Taylor - DRC
David Rendall - DRC
Who are the major shareholders of PURE Biosciences Inc?

Here are the top five shareholders of PURE Biosciences Inc based on the size of their shareholding:

Plum Investments, L.P. Corporation
Percentage owned: 15.37% (13.4m shares)
Lee (Tom Y) Individual Investor
Percentage owned: 9.82% (8.56m shares)
Okuno (Dale A) Individual Investor
Percentage owned: 8.11% (7.07m shares)
Chen (Ivan) Individual Investor
Percentage owned: 0.52% (450k shares)
Myers (Thomas Richard) Individual Investor
Percentage owned: 0.37% (320k shares)
Similar to PURE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.